Predicting health-related quality of life (EQ-5D-5 L) and capability wellbeing (ICECAP-A) in the context of opiate dependence using routine clinical outcome measures: CORE-OM, LDQ and TOP

Abstract

BackgroundEconomic evaluation normally requires information to be collected on outcome improvement using utility values. This is often not collected during the treatment of substance use disorders making cost-effectiveness evaluations of therapy difficult. One potential solution is the use of mapping to generate utility values from clinical measures. This study develops and evaluates mapping algorithms that could be used to predict the EuroQol-5D (EQ-5D-5 L) and the ICEpop CAPability measure for Adults (ICECAP-A) from the three commonly used clinical measures; the CORE-OM, the LDQ and the TOP measures.MethodsModels were estimated using pilot trial data of heroin users in opiate substitution treatment. In the trial the EQ-5D-5 L, ICECAP-A, CORE-OM, LDQ and TOP were administered at baseline, three and twelve month time intervals. Mapping was conducted using estimation and validation datasets. The normal estimation dataset, which comprised of baseline sample data, used ordinary least squares (OLS) and tobit regression methods. Data from the baseline and three month time periods were combined to create a pooled estimation dataset. Cluster and mixed regression methods were used to map from this dataset. Predictive accuracy of the models was assessed using the root mean square error (RMSE) and the mean absolute error (MAE). Algorithms were validated using sample data from the follow-up time periods.ResultsMapping algorithms can be used to predict the ICECAP-A and the EQ-5D-5 L in the context of opiate dependence. Although both measures can be predicted, the ICECAP-A was better predicted by the clinical measures. There were no advantages of pooling the data. There were 6 chosen mapping algorithms, which had MAE scores ranging from 0.100 to 0.138 and RMSE scores ranging from 0.134 to 0.178.ConclusionIt is possible to predict the scores of the ICECAP-A and the EQ-5D-5 L with the use of mapping. In the context of opiate dependence, these algorithms provide the possibility of generating utility values from clinical measures and thus enabling economic evaluation of alternative therapy options.Trial registrationISRCTN22608399. Date of registration: 27/04/2012. Date of first randomisation: 14/08/2012.Electronic supplementary materialThe online version of this article (10.1186/s12955-018-0926-7) contains supplementary material, which is available to authorized users.

Estimation of minimally important difference of the EQ-5D-5L utility scores among patients with either hypertension or diabetes or both: a cross-sectional study in Hong Kong

“…14 For patients with chronic conditions, the outcomes of healthcare should not be evaluated to restore physical health but to improve their HRQoL in order for them to live in independence, dignity and comfort. 33 The MID estimate in multimorbidity of chronic conditions is essential for providing meaningful interpretation of the effects of an intervention on HRQoL and to classify changes in patient well-being.…”

Measurement of health-related quality by multimorbidity groups in primary health care

“…Although few individuals were included in the population integrated into the groups with higher morbidity (8 and 9), a sample was obtained with a homogeneous number of individuals in all the groups, with 306 patients in all. Other similar studies [31, 32, 34] used smaller samples, with 238 patients and 83 patients, respectively. Selecting sample with subjects aged over 18 provided us with a mean age of 53 years, which is older than that of the general population (39.2 years).…”

Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway

“…The EQ-5D-5L instrument is a widely used generic measure of HRQoL [34] and validated for opioid use disorders [35,36]. It consists of two components.…”